🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#cirrhosis pearl give a fluid bolus If a patient is confused & you suspect hepatic encephalopathy. 80% of the time, it works every time. Higher if you think they are dried out from diuretics more on HE Physiology mayoclinicproceedings.org/retrieve/pii/S… pubmed.ncbi.nlm.nih.gov/32224704/?from… #LiverTwitter

Insightful and balanced editorial regarding our study in HEPATOLOGY Journal Drs. Lok and Dusheiko summarize the current landscape and potential expansion of Rx indications for hepatitis B ‼️ Patient-centered approach is the key journals.lww.com/hep/Citation/9… journals.lww.com/hep/Abstract/9…

Medications for alcohol-use disorder are an under-utilized intervention that could save lives Read: open-access editorial by Sarah Wakeman journals.lww.com/hepcomm/Fullte… See the article by @RabieeAnahita journals.lww.com/hepcomm/Fullte… Feel the 🔥 and join the movement to improve outcomes

🆕#CPG in press❕ EASL Clinical Practice Guidelines on #ACLF 🆓Find it here👉bit.ly/432zRnF EASL Education EASLnews #acuteonchronicliverfailure #LiverTwitter

Many patients with #cirrhosis have abnormal blood counts Low platelets are most common (Sequestration, ⬇️tpo, ⬆️destruction) But so are low red and white cells The yield of bone marrow biopsy for myelodysplasia is <1% doi.org/10.3390/jcm121… #livertwitter

In immunosuppression management, the balancing act between achieving tolerance and minimizing side effects can be complicated. Here's a great read from ClinicalLiverDisease about the common side effects of immunosuppression: journals.lww.com/cld/Fulltext/2… #livertwitter #GITwitter RUSH Internal Medicine

#GITwitter #LiverTwitter 🔥Happy to share our study in Gut Journal with prof Rohit Loomba on the🌐 prevalence of #NAFLD in #T2DM. ➡️35.54% had F2-4, 14.95% had F3-4 within #NAFLD, and up to 23.62% with F3-4 in #NASH.❗️Important to reduce the global burden! gut.bmj.com/content/early/…

In this large, multicenter study, Huang and colleagues demonstrate that liver fibrosis progresses faster in people with diabetes, compared to people without diabetes Daniel Huang Rohit Loomba ➡️ ow.ly/TzUK50PvXZR

Acute-on-Chronic Liver Failure Clinical Practice Guidelines (EASL, 2023) - goo.gl/alerts/8iMqGi #GoogleAlerts

Acute-on-Chronic Liver Failure Clinical Practice Guidelines (EASL, 2023) - bit.ly/3qG3HBl #Liver EASLnews

Drumroll....the 1st #LCN publication AJG - The American Journal of Gastroenterology Important ?? 🔑What is #cirrhosis? 🔑Define endpoints 🔑What is recompensation? Elliot Tapper Dr. Bobby Brown Norah Terrault Vijay Shah NIAAA News National Cancer Institute ACG Read journals.lww.com/ajg/abstract/9… More lcnstudy.org

Does liver stiffness progress faster in diabetes? Does HbA1c impact progression? Does LSM track changes in liver histology? Our prospective, multicentre study of biopsy-proven MASLD, out today HEPATOLOGY Journal MASLD Research Center Rohit Loomba AASLD journals.lww.com/hep/abstract/9…

📢Check our August issue ‼️ 💥Featured article: EASL position paper on clinical follow-up after HCV cure🔗bit.ly/3Va2uh2 Full issue here👉bit.ly/36khmDF #LiverTwitter Paolo Angeli EASL Education EASLnews

Enjoyed ✍️ this under the guidance of Prof. ⁦Ashwani Singal⁩ & Prof. Patrick Kamath. research priorities for AL(U)D ⁦Ramon Bataller⁩ ⁦Juan Pablo (JP) Arab, MD ⁩⁩ ⁦⁦⁦Jasmohan Bajaj⁩ Thomas G. Cotter, MD MS⁩ ⁦Sumeet Asrani⁩ #livertwitter search.app/pi7khfJYjAHdZW…

Kicking off our first hepatocellular carcinoma consensus meeting. Working together to turn the tide. Stay tuned!

Must read paper on azathioprine dosing in autoimmune hepatitis in HEPATOLOGY Journal This summary figure is gold 1. TGN target 2. When to add allopurinol

Thanks to the FattyLiverAlliance for capturing my comments at yesterday's events. Greatly appreciated.

Another wonderful, insightful, collaborative comment from Arun J. Sanyal, from yesterday’s United Nations General Assembly side event. “Many of the care pathways will need to be modified and adapted to be implementable in different parts of the world. But these are solvable

Thanks to Medscape for sharing my thoughts about GLP-1 RAs in the article, "Can We Repurpose Obesity Drugs to Reverse Liver Disease?" I look forward to more discussions about this class of drugs at #TLM2024. wb.md/3C7fvSI #livertwitter AASLD

In this international, collaborative effort led by Douglas Chee, we estimate the presence of health policies directed at reducing the burden of HCC CGH American Gastroenterological Association (AGA) Jörn Schattenberg Cheng Han Ng Arndt Vogel Yong Loo Lin School of Medicine Rashid Lui 雷諾信 Jimmy Che-To Lai cghjournal.org/article/S1542-…